Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Varicella-zoster virus as a live recombinant vaccine

Varicella-zoster virus as a live recombinant vaccine

US Patent 5310668 · Granted May 10, 1994

Estimated economic value: $20,289,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized antibodies to cluster of differentiation 3 (CD3)2018
Methods and compositions with immune therapy for treatment of dementia2018
Protein delivery system using human papillomavirus virus-like particles2006
Production of chimeric human papillomavirus2005
Assays for compounds that modulate rhadino virus LANA action in trans on a unit 2004
Non-defective Epstein-Barr viral vector2003
Rhadino virus LANA acts in trans on a unit of rhadino virus DNA to mediate effic2001
Method of increasing production of disulfide bonded recombinant proteins by sacc2001
Conjugates useful in the treatment of benign prostatic hyperplasia2001
Haematopoietic cytokine Epstein Barr virus-induced protein1998
Production of recombinant human papillomavirus type II protein utilizing papillo1998
Methods of detection of epstein barr virus induced genes expressed in the placen1998